Microenvironment‐Dependent MSC Immunoregulation in Type 1 Diabetes: Insights From IFNγ Preconditioning
Genes to Cells · 2025-07 · 30 (4)
DOI: 10.1111/gtc.70032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes to Cells, online erschienen am 10.06.2025. Verfasst von Seyed Mehdi Hoseini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Mesenchymal Stem Cells, Interferon-gamma, Cellular Microenvironment. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Yazd Diabetic Research Centre, Shahid Sadoughi University of Medical Sciences.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Interferon‐gamma (IFNγ) plays a crucial role in the pathogenesis of type 1 diabetes (T1D) and is widely utilized to license mesenchymal stem/stromal cells (MSCs) to enhance their immunosuppressive properties through a process known as preconditioning or priming. This study investigates the interaction of MSCs preconditioned with (IFNγ + ) or without (IFNγ − ) IFNγ, with peripheral blood mononuclear cells (PBMCs) from healthy controls (HC) and T1D patients. We assessed the effects of these interactions on anti‐inflammatory gene expression, chemokine and receptor profiles, and the induction of regulatory T (Treg) cells. Our findings reveal contrasting responses in HC and T1D PBMCs when exposed to IFNγ + and IFNγ − MSCs, particularly in the expression of key genes such as CXCR3 and its ligands ( CXCL9 , CXCL10 ), CXCR6 , CCR5 , and its ligands ( CCL3 and CCL4 ). Pathway enrichment analysis further showed that IFNγ preconditioning tailors MSC responses to specific immune microenvironments. These differential gene expression patterns were also reflected in the proportions of Treg cells, which varied depending on whether paracrine signaling or direct cell contact was involved. Collectively, our results demonstrate that IFNγ + and IFNγ − MSCs create distinct immunomodulatory microenvironments in T1D PBMCs compared to HC PBMCs, emphasizing the potential for tailored MSC‐based therapies in T1D treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biotechnology Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
- Hematology and Oncology Research Center, Non-Communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
- Biology Department, Science and Arts University, Yazd, Iran.
- Yazd Diabetic Research Centre, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
- Abortion Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
ORCID-Profile: Seyed Mehdi Hoseini, Mohammad Yahya Vahidi Mehrjardi, Mohammad Hasan Sheikhha, Fateme Montazeri
Förderung
- Yazd Diabetic Research Centre, Shahid Sadoughi University of Medical Sciences
Zitieren
APA
Hoseini, S. M., Moghimi, F., Hosseini, E. S., Miresmaeili, S. M., Mehrjardi, M. Y. V., Dehghani, M., Sheikhha, M. H., & Montazeri, F. (2025). Microenvironment‐Dependent MSC Immunoregulation in Type 1 Diabetes: Insights From IFNγ Preconditioning. Genes to Cells, 30(4). https://doi.org/10.1111/gtc.70032
Vancouver
Hoseini SM, Moghimi F, Hosseini ES, Miresmaeili SM, Mehrjardi MYV, Dehghani M, et al. Microenvironment‐Dependent MSC Immunoregulation in Type 1 Diabetes: Insights From IFNγ Preconditioning. Genes to Cells. 2025;30(4). doi:10.1111/gtc.70032
BibTeX
@article{Hoseini2025,
author = {Hoseini, Seyed Mehdi and Moghimi, Farnoosh and Hosseini, Elham Sadat and Miresmaeili, Seyed Mohsen and Mehrjardi, Mohammad Yahya Vahidi and Dehghani, Mohammadreza and Sheikhha, Mohammad Hasan and Montazeri, Fateme},
title = {Microenvironment‐Dependent MSC Immunoregulation in Type 1 Diabetes: Insights From IFNγ Preconditioning},
journal = {Genes to Cells},
year = {2025},
volume = {30},
number = {4},
doi = {10.1111/gtc.70032}
}
EUVIMED